Where is OMNI headquartered?

OMNI is located in Shanghai, Shanghai.

Who invested in OMNI?

OMNI has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for OMNI?

OMNI closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

omni-pharma.com

OMNI

OMNI is a pharmaceutical company that focuses on drug delivery technologies.

Business Model:

Revenue: $0

Employees: 201-500

Rankings

Industries / Tags:

Detailed OMNI Information

General Information

Geographic Data

Address:

City: Shanghai

State: Shanghai

Zip:

Country: China

Financial Info

Stage:

series d

Raised Last:

$0

Raised Total:

$5M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2017	Series B	3	$3M	SDIC Venture Capital Shiyao Biomedical Technology Vivo Olive Surplus HK VIII Limited SDIC Venture Capital Shiyao Biomedical Technology Vivo Olive Surplus HK VIII Limited
11/2017	Series C	2	-	SDIC Venture Capital Vivo Capital SDIC Venture Capital Vivo Capital
12/2021	Series D		-	Bank of China Group Investment Shanghai Biomedical Industrial Equity Investment Fund Zhangkelingyi Bank of China Group Investment Shanghai Biomedical Industrial Equity Investment Fund Zhangkelingyi
9/2015	Series A	2	$1.6M	Shanghai Chenshan Investment Management Shanghai Liyi Investment Management Shanghai Chenshan Investment Management Shanghai Liyi Investment Management
2/2013	Angel Round	1	$479.7k	Haimen Pushi Yiyao Haimen Pushi Yiyao
3/2021	Series D	1	-	Vivo Capital Vivo Capital
12/2021	Series D	3	-	Bank of China Group Investment Shanghai Biomedical Industrial Equity Investment Fund Zhangkelingyi Bank of China Group Investment Shanghai Biomedical Industrial Equity Investment Fund Zhangkelingyi
3/2021	Series D	1	-	Vivo Capital Vivo Capital
11/2017	Series C	2	-	SDIC Venture Capital Vivo Capital SDIC Venture Capital Vivo Capital
9/2017	Series B	3	$3M	SDIC Venture Capital Shiyao Biomedical Technology Vivo Olive Surplus HK VIII Limited SDIC Venture Capital Shiyao Biomedical Technology Vivo Olive Surplus HK VIII Limited
9/2015	Series A	2	$1.6M	Shanghai Chenshan Investment Management Shanghai Liyi Investment Management Shanghai Chenshan Investment Management Shanghai Liyi Investment Management
2/2013	Angel Round	1	$479.7k	Haimen Pushi Yiyao Haimen Pushi Yiyao

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details